2025-04-11 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**0) Summary Statistics:**

* **Ticker:** UNH
* **Company:** UnitedHealth Group Inc. (A diversified healthcare company offering a range of health benefits and services.)
* **Cumulative Return (UNH):** 81.04%
* **Cumulative Return (VOO/S&P 500):** 62.49%
* **Return Difference (UNH - VOO):** 18.6%
* **Relative Divergence:** 63.1% (Indicates UNH's performance is in the 63.1st percentile of its historical performance relative to the S&P 500.)


**1) Performance Comparison and Alpha/Beta Analysis:**

UNH significantly outperformed the S&P 500 (VOO) over the analyzed period, with a cumulative return 18.6% higher.  The relative divergence suggests this outperformance is relatively high compared to its historical performance relative to the S&P 500.

The Alpha/Beta analysis shows varying performance across different periods. While Alpha (measure of outperformance relative to the market) was generally positive, indicating above-market returns, it fluctuated considerably. Beta (a measure of volatility relative to the market) consistently remained above 0.1, suggesting higher volatility than the overall market. Note that the market capitalization (Cap(B)) shows consistent growth throughout the period.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 64.0% | 56.1% | 35.0% | 0.1 | 181.2 |
| 2016-2018  | 55.0% | 63.9% | 37.0% | 0.2 | 207.5 |
| 2017-2019  | 41.0% | 63.9% | 11.0% | 0.3 | 249.0 |
| 2018-2020  | -20.0% | 63.9% | -45.0% | 0.5 | 301.9 |
| 2019-2021  | 34.0% | 60.8% | -20.0% | 0.6 | 438.3 |
| 2020-2022  | 28.0% | 67.1% | 22.0% | 0.6 | 468.7 |
| 2021-2023  | 35.0% | 67.6% | 18.0% | 0.4 | 472.5 |
| 2022-2024  | -27.0% | 68.8% | -44.0% | 0.3 | 461.1 |
| 2023-2025  | 4.0% | 73.2% | -6.0% | 0.2 | 550.1 |


**2) Recent Price Movement:**

* **Closing Price:** 600.94
* **Last Market Price:** 601.64
* **5-day Moving Average:** 548.84
* **20-day Moving Average:** 519.93
* **60-day Moving Average:** 512.50

The stock price (601.64) is significantly above all moving averages, suggesting a recent upward trend.  The large price change of 4.0 from the previous close indicates a substantial positive movement.  This could be considered a rapid increase.


**3) Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4271 (Medium Risk)
* **RSI:** 83.40 (Overbought territory, suggesting potential for a price correction)
* **PPO:** 1.31 (Positive, indicating bullish momentum)
* **20-day Relative Divergence Change:** +38.6 (Significant short-term upward movement)
* **Expected Return:** 8.8% (Long-term, 2+ years, exceeding S&P 500 returns)

The high RSI value warrants caution, suggesting the possibility of an impending price correction despite the positive PPO and strong recent price movement. The positive relative divergence confirms the recent upward momentum.  The expected return is attractive, indicating potential outperformance over the long term.


**4) Recent Earnings Analysis:**

| Date       | EPS    | Revenue       |
|------------|--------|----------------|
| 2024-11-04 | 6.56   | $100.82 B      |
| 2024-08-09 | 4.58   | $98.86 B      |
| 2024-05-09 | -1.53  | $99.80 B      |
| 2023-11-06 | 6.31   | $92.36 B      |
| 2024-11-04 | 6.31   | $92.36 B      | *(Duplicate entry - Potential data error)*

Revenue remains consistently high, fluctuating around $100B. EPS shows significant volatility, with a notable negative EPS in Q2 2024.  Data cleaning is needed to address the duplicated entry.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|------------|---------------|
| 2024-12-31 | $100.81B  | 21.14%        |
| 2024-09-30 | $100.82B  | 22.84%        |
| 2024-06-30 | $98.86B   | 22.31%        |
| 2024-03-31 | $99.80B   | 23.05%        |
| 2023-12-31 | $94.43B   | 23.30%        |

Revenue is stable and high, while profit margins are generally healthy and consistent, showing only a slight downward trend in recent quarters.


**Capital and Profitability:**

| Quarter | Equity     | ROE           |
|---------|------------|---------------|
| 2024-12-31 | $92.66B   | 5.98%         |
| 2024-09-30 | $94.53B   | 6.41%         |
| 2024-06-30 | $89.36B   | 4.72%         |
| 2024-03-31 | $86.69B   | -1.63%        |
| 2023-12-31 | $88.76B   | 6.15%         |

Equity shows some fluctuations, and ROE displays significant volatility, with a negative value in Q1 2024. This warrants further investigation into the underlying causes.


**6) Overall Conclusion:**

UNH has demonstrated strong outperformance against the S&P 500, with a high cumulative return and a generally positive alpha.  However, recent indicators suggest potential near-term volatility. The high RSI and the significant price increase warrant caution.  The company's financial health appears relatively robust, although there are some concerns raised by the volatility in EPS and ROE.  Further analysis is needed to assess the sustainability of its recent performance and to identify the reasons behind the volatility in its financial metrics.  Long-term investors should monitor the market conditions closely and assess the underlying fundamentals before making investment decisions.  The potential for long-term outperformance is there, but the risks of near-term corrections should not be underestimated.  Addressing the data inconsistencies in the earnings data is crucial for a more accurate analysis.
